0QUD3KZ
Supplement Patella, Right to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | Q Lower Bones |
| Operation | U Supplement |
| Body Part | D Patella, Right |
| Approach | 3 Percutaneous |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures in the lower bones add material - a mesh, graft, cement, or synthetic reinforcement - to strengthen or bulk up a bone that is still substantially present, rather than removing or replacing it outright. Typical uses include augmenting a thinning pelvic wall, reinforcing a healing fracture site, or filling a bone defect left after a benign lesion was scraped out.
Patients undergo this kind of procedure when a bone is structurally weak but does not need to be taken out - for example, bone grafting to fill a cavity, cement augmentation in osteoporotic bone before hardware placement, or mesh reinforcement over a thin cortical wall. The goal is to restore mechanical strength and support healing or subsequent hardware fixation, not to replace the bone's own tissue.
Anatomy & Axis Detail
Patella, Right
The patella is the sesamoid bone embedded within the quadriceps tendon that functions as a mechanical fulcrum, increasing the lever arm of knee extension while its posterior articular surface glides against the femoral trochlea. Supplementing the right patella arises with a healed fracture leaving a persistent gap, an osteochondral defect exposing subchondral bone, or thinning from chronic patellofemoral disease, where graft material restores contour and load-bearing thickness of this relatively small, flattened bone. Because the patella has limited bone stock and a critical articular surface, even small volumes of graft must be precisely contained to avoid disrupting tracking within the trochlear groove or altering extensor mechanism tension. Its superficial, subcutaneous position also makes soft tissue coverage a practical consideration in how the procedure is approached and closed.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders need documentation confirming that the patient's own bone structure remained in place and that material was added to reinforce or augment it - autograft, allograft, synthetic bone substitute, or cement all qualify, and the specific substance often drives the correct device value. The material must physically bolster the existing bone rather than simply fill dead space cosmetically.
A common mixup is coding Supplement when the correct root operation is Replacement, which applies only when the material takes over the entire function of a body part that has been made physically absent - if the bone itself was removed and replaced, that's Replacement, not Supplement. Another frequent error is missing a concurrent Excision or Repair code when the graft site was first debrided or an underlying fracture was fixed.